Ameriprise’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-169,860
| Closed | -$1.55M | – | 4173 |
|
|
2025
Q2 | $1.55M | Buy |
169,860
+104,202
| +159% | +$766K | ﹤0.01% | 3082 |
|
|
2025
Q1 | $522K | Sell |
65,658
-59,972
| -48% | -$439K | ﹤0.01% | 3469 |
|
|
2024
Q4 | $682K | Sell |
125,630
-88,350
| -41% | -$540K | ﹤0.01% | 3406 |
|
|
2024
Q3 | $1.54M | Sell |
213,980
-60,669
| -22% | -$555K | ﹤0.01% | 3037 |
|
|
2024
Q2 | $2.98M | Sell |
274,649
-84,886
| -24% | -$1.09M | ﹤0.01% | 2669 |
|
|
2024
Q1 | $6.74M | Buy |
359,535
+50,800
| +16% | +$1.17M | ﹤0.01% | 2131 |
|
|
2023
Q4 | $6.69M | Sell |
308,735
-403,689
| -57% | -$8M | ﹤0.01% | 2126 |
|
|
2023
Q3 | $14.7M | Sell |
712,424
-177,619
| -20% | -$5.13M | ﹤0.01% | 1423 |
|
|
2023
Q2 | $41.8M | Sell |
890,043
-234,775
| -21% | -$11.7M | 0.01% | 844 |
|
|
2023
Q1 | $47.2M | Buy |
1,124,818
+41,774
| +4% | +$1.8M | 0.02% | 778 |
|
|
2022
Q4 | $41.3M | Sell |
1,083,044
-10,433
| -1% | -$398K | 0.01% | 812 |
|
|
2022
Q3 | $42.8M | Buy |
1,093,477
+321,121
| +42% | +$12.4M | 0.02% | 758 |
|
|
2022
Q2 | $24.9M | Sell |
772,356
-43,265
| -5% | -$1.45M | 0.01% | 1063 |
|
|
2022
Q1 | $27M | Buy |
815,621
+37,299
| +5% | +$1.4M | 0.01% | 1125 |
|
|
2021
Q4 | $33.1M | Buy |
778,322
+91,290
| +13% | +$3.82M | 0.01% | 1049 |
|
|
2021
Q3 | $30.4M | Buy |
687,032
+82,091
| +14% | +$3.76M | 0.01% | 1000 |
|
|
2021
Q2 | $34.4M | Buy |
604,941
+157,987
| +35% | +$11.2M | 0.01% | 984 |
|
|
2021
Q1 | $33.5M | Buy |
446,954
+57,320
| +15% | +$4.7M | 0.01% | 976 |
|
|
2020
Q4 | $33.7M | Sell |
389,634
-362
| -0.1% | -$26.7K | 0.01% | 929 |
|
|
2020
Q3 | $23.8M | Buy |
389,996
+17,380
| +5% | +$881K | 0.01% | 977 |
|
|
2020
Q2 | $15.5M | Sell |
372,616
-236,098
| -39% | -$8.57M | 0.01% | 1214 |
|
|
2020
Q1 | $17.4M | Buy |
608,714
+268,789
| +79% | +$15.6M | 0.01% | 1022 |
|
|
2019
Q4 | $24.5M | Sell |
339,925
-114,910
| -25% | -$14.1M | 0.01% | 1040 |
|
|
2019
Q3 | $63.8M | Sell |
454,835
-9,788
| -2% | -$1.64M | 0.03% | 552 |
|
|
2019
Q2 | $85.1M | Buy |
464,623
+107,140
| +30% | +$18.3M | 0.04% | 468 |
|
|
2019
Q1 | $56.9M | Buy |
357,483
+105,729
| +42% | +$15.3M | 0.03% | 596 |
|
|
2018
Q4 | $24.1M | Sell |
251,754
-78,083
| -24% | -$8.94M | 0.01% | 948 |
|
|
2018
Q3 | $46.3M | Sell |
329,837
-30,104
| -8% | -$4.65M | 0.02% | 789 |
|
|
2018
Q2 | $56.3M | Buy |
359,941
+52,626
| +17% | +$8.26M | 0.02% | 617 |
|
|
2018
Q1 | $49.5M | Buy |
307,315
+128,208
| +72% | +$21.8M | 0.02% | 658 |
|
|
2017
Q4 | $29.5M | Buy |
179,107
+116,322
| +185% | +$11.3M | 0.01% | 831 |
|
|
2017
Q3 | $3.91M | Buy |
62,785
+3,449
| +6% | +$271K | ﹤0.01% | 2259 |
|
|
2017
Q2 | $4.72M | Buy |
59,336
+552
| +0.9% | +$39.9K | ﹤0.01% | 2122 |
|
|
2017
Q1 | $4.18M | Sell |
58,784
-458
| -0.8% | -$26.8K | ﹤0.01% | 2172 |
|
|
2016
Q4 | $3.02M | Sell |
59,242
-16,222
| -21% | -$765K | ﹤0.01% | 2417 |
|
|
2016
Q3 | $3.48M | Buy |
75,464
+17,372
| +30% | +$707K | ﹤0.01% | 2252 |
|
|
2016
Q2 | $1.75M | Buy |
58,092
+45,260
| +353% | +$1.51M | ﹤0.01% | 2591 |
|
|
2016
Q1 | $411K | Buy |
12,832
+1,766
| +16% | +$62.2K | ﹤0.01% | 3244 |
|
|
2015
Q4 | $646K | Sell |
11,066
-25,245
| -70% | -$1.25M | ﹤0.01% | 3146 |
|
|
2015
Q3 | $1.54M | Sell |
36,311
-1,417
| -4% | -$87.3K | ﹤0.01% | 2768 |
|
|
2015
Q2 | $2.75M | Buy |
37,728
+22,798
| +153% | +$1.47M | ﹤0.01% | 2555 |
|
|
2015
Q1 | $750K | Buy |
+14,930
| New | +$642K | ﹤0.01% | 3050 |
|
Other funds holding SAGE
IA
HNB